| Literature DB >> 32953418 |
A Türkyılmaz1, O Yaralı1.
Abstract
Trisomy 16 is the most common type of autosomal trisomy associated with spontaneous abortion and is incompatible with life. Upon examining previously reported cases of partial chromosome 16q duplication, it was noted that the majority of cases had complex chromosomal abnormalities due to parental balanced chromosomal translocation carriage. The clinical presentation of very rare pure partial trisomy 16q cases was associated with congenital anomalies, facial dysmorphic findings and intellectual disability. In this study, we evaluated the physical characteristics and genetic data of an 8-month-old girl with developmental delay and facial dysmorphic features. Dysmorphic features including prominent metopic suture, synophrys, asymmetric head shape, triangular and asymmetric face, telecanthus, epicanthal folds, down-slanting palpebral fissures, microphthalmia of the left eye, anteverted nares, smooth and tented philtrum, microretrognathia, low-set posteriorly rotated ears, auricular pits, high-arched palate, thin upper lip and hypotonia were recorded. Her karyotype was 46,XX,add(16)(q24). To identify the extension of the duplicated section, array comparative genomic hybridization (aCGH) analysis was performed, which showed a de novo 29.8 Mb duplication [arr[hgl9] 16q12.1q23.3(52459169-82285105) x 3], interpreted to be pathogenic. We present this case report to clarify the clinical findings of a rare chromosomal anomaly, discuss the genes that may be related to the phenotype and advance the literature in terms of knowledge regarding genotypephenotype correlation.Entities:
Keywords: 16q duplication; Array comparative genomic hybridization (aCGH); Partial trisomy 16
Year: 2020 PMID: 32953418 PMCID: PMC7474222 DOI: 10.2478/bjmg-2020-0009
Source DB: PubMed Journal: Balkan J Med Genet ISSN: 1311-0160 Impact factor: 0.519
Clinical features of previously reported pure partial trisomy 16q cases in the literature and in our patient.
| Partial 16q trisomy region | Prx. D. 16q11.1-q13 | Prx. D. 16q11.2-q12.2 | Prx. D. 16q11.2-q12.1 | Prx. D. 16q11.2-q13 | Prx.D. 16q 12.1-q13 | Prx-Inter. D. 16q11.2-q22.1 | Prx-Inter. D. 16q11.2-q22.3 | Prx-Inter. D. 16q12.1-q21 | Prx-Inter. D. 16q13-q22.3 | Prx-Inter. D. 16q12.1-q22.1 | Inter-Dis. D. 16q22.1-q23.1 | Inter-Dis. D. 16q13-q24 | Prx-Dis. D. 16q12.1-q23.3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methodology for genetic analysis | Conv. Cyto./ FISH | Conv. Cyto./ FISH | Conv. Cyto./ FISH | Conv. Cyto./ FISH | Conv. Cyto./ FISH | SNP-aCHG (45,086,927- 71,261,259) 26.17 Mb | Oligonu-cleotide aCGH 22.5 Mb | Oligonucleo-tide aCGH (50,843,158-60,770,795) 9.92 Mb | Conv. Cyto. | aCGH 19.8 Mb | Conv. Cyto./ FISH | Conv. Cyto. | aCGH (52,459,169- 82,285,105) 29.8 Mb |
| References | [5] | [6] | [6] | [6] | [7] | [1] | [8] | [2] | [9] | [3] | [10] | [11] | this study |
| Gender | F | M | M;M;M;M | M;M;F | M | F | F | F | F | F | M | F | F |
| Age (years) | 3 | 5 | 5.3;3;32;32 | 9.5;5;39 | NR | 2 | 5 | 3.5 | 26 | 7 | 10 | 0 | 0 |
| Growth retardation | [–] | [–] | NR | 2/3 | NR | [–] | [–] | [–] | [+] | [+] | [+] | NR | [+] |
| Intellectual disability | [+] | [+] | 3/2 | 3/3 | RN | [+] | [+] | [+] | [+] | [+] | [+] | NR | [+] |
| Micro-cephaly | [–] | NR | NR | [–] | NR | [–] | [+] | [–] | [–] | [–] | [–] | NR | [+] |
| Behavioral problems | [+] | [+] | NR | 2/3 | NR | NR | [+] | [+] | [+] | NR | [+] | NR | NR |
| Epilepsy | [-] | NR | NR | NR | NR | [–] | [–] | [–] | NR | [+] | [+] | NR | [–] |
| Speech delay | [+] | [+] | 2/4 | 2/3 | NR | [+] | [–] | [+] | [+] | NR | [+] | NR | [+] |
| Obesity | [-] | [+] | NR | 3/3 | NR | [–] | [+] | [+] | NR | NR | NR | NR | [–] |
| Dysmorphic features | [+] | [+] | NR | [–] | NR | [+] | [+] | [+] | [+] | [+] | NR | [+] | [+] |
| Ear anomalies | [+] | NR | NR | NR | NR | [+] | NR | [+] | [–] | [–] | [+] | NR | [+] |
| Eye anomalies | [-] | [+] | NR | 2/3 | NR | [+] | [+] | [+] | [–] | [+] | [–] | NR | [+] |
| Skeletal anomalies | [+] | [+] | NR | 3/3 | NR | [+] | [–] | [+] | [+] | NR | [+] | [+] | [–] |
| Heart defects | [-] | [+] | [–] | [–] | NR | [+] | [–] | [–] | NR | [–] | [–] | [+] | [–] |
| Urogenital anomalies | [-] | NR | NR | NR | NR | [–] | [–] | [–] | NR | [–] | [–] | [+] | [–] |
| CNV anomalies | [-] | NR | NR | NR | NR | [–] | [–] | [–] | NR | [+] | [+] | NR | [–] |
Prx. D.: proximal duplication; Prx-Inter. D.: proximal intermediate duplication; Inter-Dis. D.: intermediate distal duplication;
Prx-Dis. D.: proximal-distal duplication; Conv. Cyto.: conventional cytogenetic; FISH: fluorescence in situ hybridization;
SNP: single nucleotide polymorphism; aCGH: array comparative genomic hybridization; F: female; M: male; NR: not reported;
CNV: central nervous system.
Figure 1The patient’s pictures at the age of 8 months. (written informed consent was obtained from the patient’s parents for publication of proband’s)
Figure 2The patient’s karyotype: 46,XX,add(16)(q24).
Figure 3Result of 315k Affymetrix CyctoScan Optima array of chromosome 16. Enlargement of aCGH results on chromosome 16 show gain of 16ql2.1q23.3 corresponding to 29.8 Mb of DNA. X-axis corresponds to the genomic position in megabases of DNA and Y-axis show the log 2 ratio of signal intensity.